Potent EGFR tyrosine kinase inhibitors as anticancer agents

被引:0
|
作者
Shiao, Hui-Yi [1 ]
Chu, Chang-Ying [1 ]
Hsu, John T. -A. [1 ]
Yeh, Teng-Kuang [1 ]
Hsieh, Hsing-Pang [1 ]
机构
[1] Natl Hlth Res Inst, Inst Biotechnol & Pharmaceut Res, Zhunan, Miaoli, Taiwan
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
257-MEDI
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Aurora-kinase inhibitors as anticancer agents
    Nicholas Keen
    Stephen Taylor
    Nature Reviews Cancer, 2004, 4 : 927 - 936
  • [32] Aurora-kinase inhibitors as anticancer agents
    Keen, N
    Taylor, S
    NATURE REVIEWS CANCER, 2004, 4 (12) : 927 - 936
  • [33] Structural Insight and Development of EGFR Tyrosine Kinase Inhibitors
    Amelia, Tasia
    Kartasasmita, Rahmana Emran
    Ohwada, Tomohiko
    Tjahjono, Daryono Hadi
    MOLECULES, 2022, 27 (03):
  • [34] EGFR Tyrosine Kinase Inhibitors: Difference in Efficacy and Resistance
    Kyle W. Robinson
    Alan B. Sandler
    Current Oncology Reports, 2013, 15 : 396 - 404
  • [35] New tyrosine kinase and EGFR inhibitors in cancer therapy
    Rottlaender, D.
    Reda, S.
    Motloch, L. J.
    Hoppe, U. C.
    INTERNIST, 2011, 52 (10): : 1245 - +
  • [36] EGFR Tyrosine Kinase Inhibitors: Difference in Efficacy and Resistance
    Robinson, Kyle W.
    Sandler, Alan B.
    CURRENT ONCOLOGY REPORTS, 2013, 15 (04) : 396 - 404
  • [37] EGFR tyrosine kinase inhibitors and multidrug resistance: perspectives
    Colabufo, Nicola A.
    Contino, Marialessandra
    Niso, Mauro
    Berardi, Francesco
    Leopoldo, Marcello
    Perrone, Roberto
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2011, 16 : 1811 - 1823
  • [38] Novel Benzimidazole Analogs as Inhibitors of EGFR Tyrosine Kinase
    Yadav, Soni
    Sinha, Deepa
    Singh, Sanjay K.
    Singh, Vinay K.
    CHEMICAL BIOLOGY & DRUG DESIGN, 2012, 80 (04) : 625 - 630
  • [39] Factors predicting response to EGFR tyrosine kinase inhibitors
    Engelman, JA
    Jänne, PA
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 26 (03) : 314 - 322
  • [40] Redundant kinase activation and resistance of EGFR-tyrosine kinase inhibitors
    Luo, Min
    Fu, Li-Wu
    AMERICAN JOURNAL OF CANCER RESEARCH, 2014, 4 (06): : 608 - 628